ABSTRACT
Gonadotropin-releasing hormone (GnRH) neurons control mammalian reproduction and migrate from their birthplace in the nasal placode to the hypothalamus during development. Despite much work on the origin and migration of GnRH neurons, the processes that control GnRH lineage formation are not fully understood. Here, we demonstrate that Nhlh genes control vomeronasal receptor expression in the developing murine olfactory placode associated with the generation of the first GnRH neurons at embryonic days (E)10-12. Inactivation of ß2-microglobulin (ß2-m), which selectively affects surface expression of V2Rs, dramatically decreased the number of GnRH neurons in the Nhlh2 mutant background, preventing rescue of fertility in female Nhlh2 mutant mice by male pheromones. In addition, we show that GnRH neurons generated after E12 fail to establish synaptic connections to the vomeronasal amygdala, suggesting the existence of functionally specialized subpopulations of GnRH neurons, which process pheromonal information.
Subject(s)
Gonadotropin-Releasing Hormone/metabolism , Neurogenesis/genetics , Neurons/metabolism , Receptors, Pheromone/genetics , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Cells, Cultured , Chemotactic Factors/genetics , Embryo, Mammalian , Female , Gene Expression Regulation, Developmental , Hypothalamus/embryology , Hypothalamus/metabolism , Male , Mice , Mice, Knockout , Neurons/physiology , Pheromones/metabolism , Pregnancy , Receptors, Pheromone/metabolismABSTRACT
A large family of vomeronasal receptors recognizes pheromone cues in many animals including most amphibia, reptiles, rhodents, and other mammals. Humans possess five vomeronasal-type 1 receptor genes (VN1R1-VN1R5), which code for proteins that are functional in recombinant expression systems. We used two different recombinant expression systems and identified Hedione as a ligand for the putative human pheromone receptor VN1R1 expressed in the human olfactory mucosa. Following the ligand identification, we employed functional magnetic resonance imaging (fMRI) in healthy volunteers to characterize the in vivo action of the VN1R1 ligand Hedione. In comparison to a common floral odor (phenylethyl alcohol), Hedione exhibited significantly enhanced activation in limbic areas (amygdala, hippocampus) and elicited a sex-differentiated response in a hypothalamic region that is associated with hormonal release. Utilizing a novel combination of methods, our results indicate that the putative human pheromone receptor VN1R1 is involved in extra-olfactory neuronal activations induced by the odorous substance Hedione. The activation of VN1R1 might play a role in gender-specific modulation of hormonal secretion in humans.
Subject(s)
Cyclopentanes/pharmacology , Pheromones, Human/pharmacology , Smell/physiology , Adult , Calcium Signaling/drug effects , Chemotactic Factors/genetics , Chemotactic Factors/physiology , Female , HEK293 Cells , Humans , Hypothalamus/drug effects , Limbic System/drug effects , Magnetic Resonance Imaging , Male , Olfactory Mucosa/drug effects , Olfactory Mucosa/metabolism , Polymerase Chain Reaction , Receptors, Pheromone/drug effects , Receptors, Pheromone/genetics , Sex Characteristics , Transfection , Young AdultABSTRACT
S100A2 is a Ca(2+)-binding EF-hand protein that is mainly localized in the nucleus. There, it acts as a tumour suppressor by binding and activating p53. Wild-type S100A2 and a S100A2 variant lacking cysteines have been purified. CD spectroscopy showed that there are no changes in secondary-structure composition. The S100A2 mutant was crystallized in a calcium-free form. The crystals, with dimensions 30 x 30 x 70 microm, diffract to 1.7 A and belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 43.5, b = 57.8, c = 59.8 A, alpha = beta = gamma = 90 degrees. Preliminary analysis of the X-ray data indicates that there are two subunits per asymmetric unit.
Subject(s)
Chemotactic Factors/chemistry , Chemotactic Factors/isolation & purification , S100 Proteins/chemistry , S100 Proteins/isolation & purification , Chemotactic Factors/genetics , Crystallization , DNA, Complementary , Humans , Protein Structure, Secondary , Protein Subunits/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , S100 Proteins/genetics , X-Ray DiffractionABSTRACT
The Duffy Ag expressed on RBCs, capillaries, and postcapillary venular endothelial cells binds selective CXC and CC chemokines with high affinity. Cells transfected with the Duffy Ag internalize but do not degrade chemokine ligand. It has been proposed that Duffy Ag transports chemokines across the endothelium. We hypothesized that Duffy Ag participates in the movement of chemokines across the endothelium and, by doing so, modifies neutrophil transmigration. We found that the Duffy Ag transfected into human endothelial cells facilitates movement of the radiolabeled CXC chemokine, growth related oncogene-alpha/CXC chemokine ligand 1 (GRO-alpha/CXCL1), across an endothelial monolayer. In addition, neutrophil migration toward GRO-alpha/CXCL1 and IL-8 (IL-8/CXCL8) was enhanced across an endothelial monolayer expressing the Duffy Ag. Furthermore, GRO-alpha/CXCL1 stimulation of endothelial cells expressing the Duffy Ag did not affect gene expression by oligonucleotide microarray analysis. These in vitro observations are supported by the finding that IL-8/CXCL8-driven neutrophil recruitment into the lungs was markedly attenuated in transgenic mice lacking the Duffy Ag. We conclude that Duffy Ag has a role in enhancing leukocyte recruitment to sites of inflammation by facilitating movement of chemokines across the endothelium.
Subject(s)
Chemokines, CXC , Chemokines/metabolism , Chemotactic Factors/metabolism , Duffy Blood-Group System/physiology , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Neutrophil Infiltration/immunology , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cell Line, Transformed , Chemokine CXCL1 , Chemokines/genetics , Chemotactic Factors/genetics , Cloning, Molecular , DNA, Complementary/isolation & purification , Duffy Blood-Group System/biosynthesis , Duffy Blood-Group System/genetics , Duffy Blood-Group System/metabolism , Female , Gene Expression Regulation/immunology , Humans , Intercellular Signaling Peptides and Proteins/genetics , Interleukin-8/administration & dosage , Interleukin-8/metabolism , Intubation, Intratracheal , Iodine Radioisotopes/metabolism , Ligands , Lung/cytology , Lung/immunology , Lung/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Neutrophil Infiltration/genetics , Protein Binding/immunology , TransfectionABSTRACT
A suppression subtraction cDNA library representing mRNAs expressed at a higher level in a benign breast tumour-derived cell line relative to the malignant MCF-7A cell line contained cDNAs corresponding to mRNAs for plasminogen activator inhibitor I, annexin VIII and the EF-hand protein S100A2. S100A2 protein has previously been shown to be expressed in normal human breast epithelium, but not in human breast carcinoma cell lines. Using a PCR-based assay and in situ hybridization on histological sections of human breast specimens, the mRNA for S100A2 was shown to be present in all benign breast lesions examined as well as in normal epithelium. S100A2 mRNA was detectable in 37% of specimens of carcinoma in situ, but in less than 15% of carcinoma specimens. The results suggest that the loss of S100A2 is associated with the development of malignant cells and is not associated with early tumour development.
Subject(s)
Breast Neoplasms/metabolism , Chemotactic Factors/biosynthesis , S100 Proteins/biosynthesis , Blotting, Northern , Breast/metabolism , Breast/physiology , Breast Neoplasms/genetics , Carcinoma in Situ/genetics , Carcinoma in Situ/metabolism , Cell Line , Chemotactic Factors/genetics , DNA, Complementary/genetics , DNA, Neoplasm/genetics , Epithelial Cells/metabolism , Epithelial Cells/physiology , Humans , In Situ Hybridization , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , S100 Proteins/genetics , Tumor Cells, Cultured , Tumor Suppressor Protein p53/biosynthesisABSTRACT
Rat cytokine-induced neutrophil chemoattractant-1 (CINC-1), CINC-2 and CINC-3/macrophage inflammatory protein-2 (MIP-2), members of the CXC chemokine family, are potent chemotactic factors for neutrophils. In order to identify the receptor for CINCs, rat CXC chemokine receptor 2 (CXCR2) was cloned and expressed in HEK293 cells. CINC-1, CINC-2 and CINC-3 induced calcium mobilizations dose-dependently in CXCR2-transfected cells, whereas formyl-methionyl-leucyl-phenylalanine (FMLP) did not. CINC-3 induced enhancement of cytoplasmic calcium concentration more potently than CINC-1 and CINC-2, and desensitized calcium transients induced by CINC-1 and CINC-2, which were essentially identical to those observed in rat neutrophils. In addition, anti-CXCR2 serum inhibited neutrophil chemotactic activities of three types of CINCs almost completely. The mutant CINC-3, whose amino-terminal amino acid sequence (SELR) was replaced to AAR, lost chemotactic activity of its own but inhibited that of CINC-1 and CINC-2 potently, and that of CINC-3 weakly. The results indicate that rat CXCR2 on neutrophils is the unique receptor for all three types of CINCs, and CINC-1/-2 and CINC-3 exert different biological activities through the common receptor.
Subject(s)
Chemokines, CXC , Chemotactic Factors/genetics , Chemotactic Factors/metabolism , Growth Substances/genetics , Growth Substances/metabolism , Intercellular Signaling Peptides and Proteins , Animals , Blotting, Northern , Calcium/metabolism , Cell Line , Chemokine CXCL1 , Chemokine CXCL2 , Chemotactic Factors/pharmacology , Chemotactic Factors/physiology , Chemotaxis/drug effects , Cloning, Molecular , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Growth Substances/pharmacology , Growth Substances/physiology , Humans , Liver/metabolism , Mutagenesis , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/metabolism , Polymerase Chain Reaction , Rats , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/metabolism , Spectrophotometry , Time Factors , TransfectionABSTRACT
To investigate lymphocyte and monocyte recruitment-specific chemokine expression in synovial tissues from patients with rheumatoid arthritis (RA), psoriatic arthritis (PA) and osteoarthritis (OA), synovial membranes and cytocentrifuge preparations of 7 RA, 8 PA and 10 OA patients were examined by in situ hybridisation with antisense probes of Mig, GRO alpha and RANTES and by immunohistochemistry. Patients' local disease activity (swelling and tenderness) in order to was graded and histological evaluation was performed compare these data with their chemokine expression profiles. Mig and RANTES hybridisation signals were detected in the synovial lining layer and in cellular infiltrates, whereas GRO alpha expression was localised exclusively in the lining layer of PA and RA. Cytological analysis revealed Mig and GRO alpha mRNA mainly in monocytic cells expressing KIM6, while RANTES mRNA was demonstrated predominantly in lymphocytic cells expressing CD3. In OA synovial membranes, significantly fewer hybridisation signals were present than in RA and PA synovial membranes. Patients with PA and RA had mild to severe local disease activity, whereas OA patients showed only mild disease activity. Histologically, PA and RA inflammatory scores ranged from 1 to 5, while OA synovium was consistently graded 1. Therefore, we conclude that the differential expression of Mig, GRO alpha and RANTES in resident and in inflammatory cells has an important role in regulating leucocyte traffic in inflammatory arthropathies. The diverse leucocyte specificity of Mig, GRO alpha and RANTES may thus regulate the recruitment of different leucocyte populations, as detected in PA and RA. Therefore, the pattern of cellular infiltration in human synovitis and the corresponding clinical signs of inflammation basically reflect the localisation and expression intensity of chemokines, which may be an important target for future disease modulation.
Subject(s)
Arthritis/genetics , Chemokine CCL5/genetics , Chemokines, CXC/genetics , Chemotactic Factors/genetics , Growth Substances/genetics , Intercellular Signaling Peptides and Proteins , Leukocytes, Mononuclear/metabolism , RNA, Messenger/biosynthesis , Synovial Membrane/metabolism , Adult , Aged , Aged, 80 and over , Arthritis/metabolism , Arthritis/pathology , Arthritis, Psoriatic/genetics , Arthritis, Psoriatic/metabolism , Arthritis, Psoriatic/pathology , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/metabolism , Arthritis, Rheumatoid/pathology , Cell Count , Chemokine CCL5/metabolism , Chemokine CXCL1 , Chemokine CXCL9 , Chemokines, CXC/metabolism , Chemotactic Factors/metabolism , Female , Growth Substances/metabolism , Humans , Immunohistochemistry , In Situ Hybridization , Male , Middle Aged , Osteoarthritis/genetics , Osteoarthritis/metabolism , Osteoarthritis/pathology , Synovial Membrane/pathologyABSTRACT
PROBLEM: We previously reported that a cytokine-induced neutrophil chemoattractant (CINC) was produced in the pituitary gland and that it influenced anterior pituitary hormone release. In this study we investigated the effect of Unkei-to, a Japanese herbal medicine, on CINC production in the rat anterior pituitary gland and the pituitary folliculo-stellate-like cell line (TtT/GF). METHOD OF STUDY: Dispersed normal anterior pituitary cells and the folliculo-stellate-like cell line TtT/GF were used to test the effect of Unkei-to on CINC secretion and CINC mRNA accumulation. Concentrations of CINC in the conditioned media were measured by an enzyme-linked immunosorbent assay, and levels of CINC mRNA were analyzed by Northern blot analysis. RESULTS: Unkei-to (20 micrograms/ml) significantly increased the secretion of CINC by normal anterior pituitary cells within 12 hr of incubation. Unkei-to also stimulated CINC secretion from TtT/GF cells in a time- and dose-dependent manner. Unkei-to (20 micrograms/ml) increased CINC mRNA accumulation in TtT/GF cells within 3 hr of incubation and also caused a 13-fold increase in the secretion of CINC from TtT/GF cells compared with the vehicle group within 24 hr of incubation. Finally, we found that some of the Unkei-to's ingredients, Evodiae fructus and Pinelliae tuber, markedly stimulated CINC secretion from TtT/GF cells. CONCLUSIONS: Our results will help to elucidate the mechanism behind the clinical effect of Unkei-to on the anterior pituitary gland. They also suggested the presence of special substances, which stimulate CINC secretion, within Unkei-to's ingredients such as E. fructus and P. tuber.
Subject(s)
Chemokines, CXC , Chemotactic Factors/metabolism , Cytokines/pharmacology , Drugs, Chinese Herbal/pharmacology , Growth Substances/metabolism , Intercellular Signaling Peptides and Proteins , Medicine, East Asian Traditional , Pituitary Gland, Anterior/drug effects , Plants, Medicinal , Animals , Cell Line , Chemotactic Factors/genetics , Dose-Response Relationship, Drug , Drug Synergism , Female , Growth Substances/genetics , Pituitary Gland, Anterior/cytology , RNA, Messenger/analysis , Rats , Rats, WistarABSTRACT
We hypothesized that endotoxin injection in rats would stimulate in vivo nuclear factor-kappa B (NF-kappa B) activation in lung tissue and that antioxidant treatment before endotoxin injection would attenuate endotoxin-induced NF-kappa B activation, chemokine gene expression, and neutrophilic lung inflammation. We studied NF-kappa B activation in rat lung tissue following a single i.p. injection of endotoxin (6 mg/kg). After in vivo endotoxin treatment, lung NF-kappa B activation peaked at 2 h and temporally correlated with the expression of cytokine-induced neutrophil chemoattractant mRNA in lung tissue. Treatment with the antioxidant N-acetylcysteine (NAC) 1 h before endotoxin resulted in decreased lung NF-kappa B activation in a dose-dependent manner (from 200-1000 mg/kg) and diminished cytokine-induced neutrophil chemoattractant mRNA expression in lung tissue. Treatment with NAC significantly suppressed endotoxin-induced neutrophilic alveolitis. The average total lung lavage neutrophil count was 5.5 x 10(6) with endotoxin treatment vs 0.9 x 10(6) with NAC treatment before endotoxin. The NF-kappa B pathway represents an attractive therapeutic target for strategies to control neutrophilic inflammation and lung injury.
Subject(s)
Acetylcysteine/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Chemokines, CXC , Chemotactic Factors/biosynthesis , Endotoxins/toxicity , Growth Substances/biosynthesis , Intercellular Signaling Peptides and Proteins , Lung Diseases/prevention & control , NF-kappa B/antagonists & inhibitors , Neutrophils/physiology , Acetylcysteine/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/therapeutic use , Base Sequence , Chemotactic Factors/genetics , Chemotaxis, Leukocyte/drug effects , Dinoprost/analogs & derivatives , Dinoprost/biosynthesis , Disease Models, Animal , Drug Evaluation, Preclinical , F2-Isoprostanes , Gene Expression Regulation/drug effects , Glutathione/biosynthesis , Glutathione/genetics , Growth Substances/genetics , Inflammation , Leukocyte Count , Lung/drug effects , Lung/metabolism , Lung Diseases/etiology , Lung Diseases/immunology , Male , Molecular Sequence Data , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Respiratory Distress Syndrome/drug therapy , Sepsis/chemically induced , Sepsis/complicationsABSTRACT
Recently we found four cytokine-induced neutrophil chemoattractants, CINC-1, CINC-2 alpha, CINC-2 beta and CINC-3/macrophage inflammatory protein 2 (MIP-2), in conditioned medium of granulation tissue obtained from carrageenin-induced inflammation in rats [Nakagawa, H., Komorita, N., Shibata, F., Ikesue, A., Konishi, K., Fujioka, M. & Kato, H. (1994) Biochem. J. 301, 545-550]. In the present report, we describe recombinant production of CINC-2 alpha, CINC-2 beta and CINC-3 in Escherichia coli, and biological properties of these chemokines. Neutrophil chemotactic activities of CINC-2 alpha and 2 beta in vitro were the same as the activity of CINC-1. CINC-3 had an activity comparable to other CINCs, but showed a decrease at high concentrations. Stimulation of neutrophils with CINCs induced an increase in intracellular [Ca2+] dose-dependently. CINC-3 was more potent than the other CINCs and still induced an increase in intracellular [Ca2+] in rat neutrophils stimulated first with other CINCs. CINC-2 alpha, CINC-2 beta and CINC-3 induced a comparable response to CINC-1 in the release of cathepsin G from rat neutrophils. Injection of CINC-2 alpha, 2 beta and 3 into preformed air-pouch on the back of rat induced infiltration of neutrophils to an extent similar to that caused by the injection of CINC-1. These data indicate CINC-2 alpha, 2 beta and 3 as well as CINC-1 are chemoattractants specific for neutrophil in vivo.